Global Oral Contrast Agent Market Growth 2025-2031

October 2025 | 121 pages | ID: G6446B02DBE4EN
LP Information

Abstracts

The global Oral Contrast Agent market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Oral Contrast Agent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oral Contrast Agent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oral Contrast Agent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oral Contrast Agent players cover GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Oral Contrast Agent Industry Forecast? looks at past sales and reviews total world Oral Contrast Agent sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Contrast Agent sales for 2025 through 2031. With Oral Contrast Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Contrast Agent industry.

This Insight Report provides a comprehensive analysis of the global Oral Contrast Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Contrast Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral Contrast Agent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Contrast Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Contrast Agent.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Contrast Agent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Barium-based Contrast Media
• Iodinated Contrast Media
• Gadolinium-based Contrast Media
• Microbubble Contrast Media

Segmentation by Application:

• Cardiovascular Disorders
• Cancer
• Gastrointestinal Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Nephrological Disorders

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GE Healthcare (US)
• Bracco Imaging (Italy)
• Bayer HealthCare (Germany)
• Guerbet (France)
• Lantheus (US)
• Daiichi Sankyo (Japan)
• Unijules Life Sciences (India)
• J.B. Chemicals and Pharmaceuticals (India)
• Spago Nanomedicine (Sweden)
• Taejoon Pharm (South Korea)
• Jodas (India)
• Magnus Health (India)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Contrast Agent market?
What factors are driving Oral Contrast Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Contrast Agent market opportunities vary by end market size?
How does Oral Contrast Agent break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Contrast Agent Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Oral Contrast Agent by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Oral Contrast Agent by Country/Region, 2020, 2024 & 2031
2.2 Oral Contrast Agent Segment by Type
  2.2.1 Barium-based Contrast Media
  2.2.2 Iodinated Contrast Media
  2.2.3 Gadolinium-based Contrast Media
  2.2.4 Microbubble Contrast Media
2.3 Oral Contrast Agent Sales by Type
  2.3.1 Global Oral Contrast Agent Sales Market Share by Type (2020-2025)
  2.3.2 Global Oral Contrast Agent Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Oral Contrast Agent Sale Price by Type (2020-2025)
2.4 Oral Contrast Agent Segment by Application
  2.4.1 Cardiovascular Disorders
  2.4.2 Cancer
  2.4.3 Gastrointestinal Disorders
  2.4.4 Musculoskeletal Disorders
  2.4.5 Neurological Disorders
  2.4.6 Nephrological Disorders
2.5 Oral Contrast Agent Sales by Application
  2.5.1 Global Oral Contrast Agent Sale Market Share by Application (2020-2025)
  2.5.2 Global Oral Contrast Agent Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Oral Contrast Agent Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Oral Contrast Agent Breakdown Data by Company
  3.1.1 Global Oral Contrast Agent Annual Sales by Company (2020-2025)
  3.1.2 Global Oral Contrast Agent Sales Market Share by Company (2020-2025)
3.2 Global Oral Contrast Agent Annual Revenue by Company (2020-2025)
  3.2.1 Global Oral Contrast Agent Revenue by Company (2020-2025)
  3.2.2 Global Oral Contrast Agent Revenue Market Share by Company (2020-2025)
3.3 Global Oral Contrast Agent Sale Price by Company
3.4 Key Manufacturers Oral Contrast Agent Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oral Contrast Agent Product Location Distribution
  3.4.2 Players Oral Contrast Agent Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ORAL CONTRAST AGENT BY GEOGRAPHIC REGION

4.1 World Historic Oral Contrast Agent Market Size by Geographic Region (2020-2025)
  4.1.1 Global Oral Contrast Agent Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Oral Contrast Agent Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Contrast Agent Market Size by Country/Region (2020-2025)
  4.2.1 Global Oral Contrast Agent Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Oral Contrast Agent Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Contrast Agent Sales Growth
4.4 APAC Oral Contrast Agent Sales Growth
4.5 Europe Oral Contrast Agent Sales Growth
4.6 Middle East & Africa Oral Contrast Agent Sales Growth

5 AMERICAS

5.1 Americas Oral Contrast Agent Sales by Country
  5.1.1 Americas Oral Contrast Agent Sales by Country (2020-2025)
  5.1.2 Americas Oral Contrast Agent Revenue by Country (2020-2025)
5.2 Americas Oral Contrast Agent Sales by Type (2020-2025)
5.3 Americas Oral Contrast Agent Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Contrast Agent Sales by Region
  6.1.1 APAC Oral Contrast Agent Sales by Region (2020-2025)
  6.1.2 APAC Oral Contrast Agent Revenue by Region (2020-2025)
6.2 APAC Oral Contrast Agent Sales by Type (2020-2025)
6.3 APAC Oral Contrast Agent Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oral Contrast Agent by Country
  7.1.1 Europe Oral Contrast Agent Sales by Country (2020-2025)
  7.1.2 Europe Oral Contrast Agent Revenue by Country (2020-2025)
7.2 Europe Oral Contrast Agent Sales by Type (2020-2025)
7.3 Europe Oral Contrast Agent Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Contrast Agent by Country
  8.1.1 Middle East & Africa Oral Contrast Agent Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Oral Contrast Agent Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Contrast Agent Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Contrast Agent Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Contrast Agent
10.3 Manufacturing Process Analysis of Oral Contrast Agent
10.4 Industry Chain Structure of Oral Contrast Agent

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oral Contrast Agent Distributors
11.3 Oral Contrast Agent Customer

12 WORLD FORECAST REVIEW FOR ORAL CONTRAST AGENT BY GEOGRAPHIC REGION

12.1 Global Oral Contrast Agent Market Size Forecast by Region
  12.1.1 Global Oral Contrast Agent Forecast by Region (2026-2031)
  12.1.2 Global Oral Contrast Agent Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Contrast Agent Forecast by Type (2026-2031)
12.7 Global Oral Contrast Agent Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GE Healthcare (US)
  13.1.1 GE Healthcare (US) Company Information
  13.1.2 GE Healthcare (US) Oral Contrast Agent Product Portfolios and Specifications
  13.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GE Healthcare (US) Main Business Overview
  13.1.5 GE Healthcare (US) Latest Developments
13.2 Bracco Imaging (Italy)
  13.2.1 Bracco Imaging (Italy) Company Information
  13.2.2 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolios and Specifications
  13.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bracco Imaging (Italy) Main Business Overview
  13.2.5 Bracco Imaging (Italy) Latest Developments
13.3 Bayer HealthCare (Germany)
  13.3.1 Bayer HealthCare (Germany) Company Information
  13.3.2 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolios and Specifications
  13.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Bayer HealthCare (Germany) Main Business Overview
  13.3.5 Bayer HealthCare (Germany) Latest Developments
13.4 Guerbet (France)
  13.4.1 Guerbet (France) Company Information
  13.4.2 Guerbet (France) Oral Contrast Agent Product Portfolios and Specifications
  13.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Guerbet (France) Main Business Overview
  13.4.5 Guerbet (France) Latest Developments
13.5 Lantheus (US)
  13.5.1 Lantheus (US) Company Information
  13.5.2 Lantheus (US) Oral Contrast Agent Product Portfolios and Specifications
  13.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Lantheus (US) Main Business Overview
  13.5.5 Lantheus (US) Latest Developments
13.6 Daiichi Sankyo (Japan)
  13.6.1 Daiichi Sankyo (Japan) Company Information
  13.6.2 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolios and Specifications
  13.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Daiichi Sankyo (Japan) Main Business Overview
  13.6.5 Daiichi Sankyo (Japan) Latest Developments
13.7 Unijules Life Sciences (India)
  13.7.1 Unijules Life Sciences (India) Company Information
  13.7.2 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolios and Specifications
  13.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Unijules Life Sciences (India) Main Business Overview
  13.7.5 Unijules Life Sciences (India) Latest Developments
13.8 J.B. Chemicals and Pharmaceuticals (India)
  13.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  13.8.2 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolios and Specifications
  13.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 J.B. Chemicals and Pharmaceuticals (India) Main Business Overview
  13.8.5 J.B. Chemicals and Pharmaceuticals (India) Latest Developments
13.9 Spago Nanomedicine (Sweden)
  13.9.1 Spago Nanomedicine (Sweden) Company Information
  13.9.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolios and Specifications
  13.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Spago Nanomedicine (Sweden) Main Business Overview
  13.9.5 Spago Nanomedicine (Sweden) Latest Developments
13.10 Taejoon Pharm (South Korea)
  13.10.1 Taejoon Pharm (South Korea) Company Information
  13.10.2 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolios and Specifications
  13.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Taejoon Pharm (South Korea) Main Business Overview
  13.10.5 Taejoon Pharm (South Korea) Latest Developments
13.11 Jodas (India)
  13.11.1 Jodas (India) Company Information
  13.11.2 Jodas (India) Oral Contrast Agent Product Portfolios and Specifications
  13.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Jodas (India) Main Business Overview
  13.11.5 Jodas (India) Latest Developments
13.12 Magnus Health (India)
  13.12.1 Magnus Health (India) Company Information
  13.12.2 Magnus Health (India) Oral Contrast Agent Product Portfolios and Specifications
  13.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Magnus Health (India) Main Business Overview
  13.12.5 Magnus Health (India) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral Contrast Agent Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Contrast Agent Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Barium-based Contrast Media
Table 4. Major Players of Iodinated Contrast Media
Table 5. Major Players of Gadolinium-based Contrast Media
Table 6. Major Players of Microbubble Contrast Media
Table 7. Global Oral Contrast Agent Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Oral Contrast Agent Sales Market Share by Type (2020-2025)
Table 9. Global Oral Contrast Agent Revenue by Type (2020-2025) & ($ million)
Table 10. Global Oral Contrast Agent Revenue Market Share by Type (2020-2025)
Table 11. Global Oral Contrast Agent Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Oral Contrast Agent Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Oral Contrast Agent Sale Market Share by Application (2020-2025)
Table 14. Global Oral Contrast Agent Revenue by Application (2020-2025) & ($ million)
Table 15. Global Oral Contrast Agent Revenue Market Share by Application (2020-2025)
Table 16. Global Oral Contrast Agent Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Oral Contrast Agent Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Oral Contrast Agent Sales Market Share by Company (2020-2025)
Table 19. Global Oral Contrast Agent Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Oral Contrast Agent Revenue Market Share by Company (2020-2025)
Table 21. Global Oral Contrast Agent Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Oral Contrast Agent Producing Area Distribution and Sales Area
Table 23. Players Oral Contrast Agent Products Offered
Table 24. Oral Contrast Agent Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Oral Contrast Agent Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Oral Contrast Agent Sales Market Share Geographic Region (2020-2025)
Table 29. Global Oral Contrast Agent Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Oral Contrast Agent Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Oral Contrast Agent Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Oral Contrast Agent Sales Market Share by Country/Region (2020-2025)
Table 33. Global Oral Contrast Agent Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Oral Contrast Agent Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Oral Contrast Agent Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Oral Contrast Agent Sales Market Share by Country (2020-2025)
Table 37. Americas Oral Contrast Agent Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Oral Contrast Agent Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Oral Contrast Agent Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Oral Contrast Agent Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Oral Contrast Agent Sales Market Share by Region (2020-2025)
Table 42. APAC Oral Contrast Agent Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Oral Contrast Agent Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Oral Contrast Agent Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Oral Contrast Agent Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Oral Contrast Agent Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Oral Contrast Agent Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Oral Contrast Agent Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Oral Contrast Agent Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Oral Contrast Agent Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Oral Contrast Agent Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Oral Contrast Agent Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Oral Contrast Agent
Table 54. Key Market Challenges & Risks of Oral Contrast Agent
Table 55. Key Industry Trends of Oral Contrast Agent
Table 56. Oral Contrast Agent Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Oral Contrast Agent Distributors List
Table 59. Oral Contrast Agent Customer List
Table 60. Global Oral Contrast Agent Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Oral Contrast Agent Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Oral Contrast Agent Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Oral Contrast Agent Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Oral Contrast Agent Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Oral Contrast Agent Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Oral Contrast Agent Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Oral Contrast Agent Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Oral Contrast Agent Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Oral Contrast Agent Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Oral Contrast Agent Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Oral Contrast Agent Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Oral Contrast Agent Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global Oral Contrast Agent Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. GE Healthcare (US) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 75. GE Healthcare (US) Oral Contrast Agent Product Portfolios and Specifications
Table 76. GE Healthcare (US) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. GE Healthcare (US) Main Business
Table 78. GE Healthcare (US) Latest Developments
Table 79. Bracco Imaging (Italy) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 80. Bracco Imaging (Italy) Oral Contrast Agent Product Portfolios and Specifications
Table 81. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Bracco Imaging (Italy) Main Business
Table 83. Bracco Imaging (Italy) Latest Developments
Table 84. Bayer HealthCare (Germany) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolios and Specifications
Table 86. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Bayer HealthCare (Germany) Main Business
Table 88. Bayer HealthCare (Germany) Latest Developments
Table 89. Guerbet (France) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 90. Guerbet (France) Oral Contrast Agent Product Portfolios and Specifications
Table 91. Guerbet (France) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Guerbet (France) Main Business
Table 93. Guerbet (France) Latest Developments
Table 94. Lantheus (US) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 95. Lantheus (US) Oral Contrast Agent Product Portfolios and Specifications
Table 96. Lantheus (US) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Lantheus (US) Main Business
Table 98. Lantheus (US) Latest Developments
Table 99. Daiichi Sankyo (Japan) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 100. Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolios and Specifications
Table 101. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Daiichi Sankyo (Japan) Main Business
Table 103. Daiichi Sankyo (Japan) Latest Developments
Table 104. Unijules Life Sciences (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 105. Unijules Life Sciences (India) Oral Contrast Agent Product Portfolios and Specifications
Table 106. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. Unijules Life Sciences (India) Main Business
Table 108. Unijules Life Sciences (India) Latest Developments
Table 109. J.B. Chemicals and Pharmaceuticals (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 110. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolios and Specifications
Table 111. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. J.B. Chemicals and Pharmaceuticals (India) Main Business
Table 113. J.B. Chemicals and Pharmaceuticals (India) Latest Developments
Table 114. Spago Nanomedicine (Sweden) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 115. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolios and Specifications
Table 116. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Spago Nanomedicine (Sweden) Main Business
Table 118. Spago Nanomedicine (Sweden) Latest Developments
Table 119. Taejoon Pharm (South Korea) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 120. Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolios and Specifications
Table 121. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 122. Taejoon Pharm (South Korea) Main Business
Table 123. Taejoon Pharm (South Korea) Latest Developments
Table 124. Jodas (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 125. Jodas (India) Oral Contrast Agent Product Portfolios and Specifications
Table 126. Jodas (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 127. Jodas (India) Main Business
Table 128. Jodas (India) Latest Developments
Table 129. Magnus Health (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 130. Magnus Health (India) Oral Contrast Agent Product Portfolios and Specifications
Table 131. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 132. Magnus Health (India) Main Business
Table 133. Magnus Health (India) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Oral Contrast Agent
Figure 2. Oral Contrast Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Contrast Agent Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Oral Contrast Agent Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Contrast Agent Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Contrast Agent Sales Market Share by Country/Region (2024)
Figure 10. Oral Contrast Agent Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Barium-based Contrast Media
Figure 12. Product Picture of Iodinated Contrast Media
Figure 13. Product Picture of Gadolinium-based Contrast Media
Figure 14. Product Picture of Microbubble Contrast Media
Figure 15. Global Oral Contrast Agent Sales Market Share by Type in 2025
Figure 16. Global Oral Contrast Agent Revenue Market Share by Type (2020-2025)
Figure 17. Oral Contrast Agent Consumed in Cardiovascular Disorders
Figure 18. Global Oral Contrast Agent Market: Cardiovascular Disorders (2020-2025) & (K Pcs)
Figure 19. Oral Contrast Agent Consumed in Cancer
Figure 20. Global Oral Contrast Agent Market: Cancer (2020-2025) & (K Pcs)
Figure 21. Oral Contrast Agent Consumed in Gastrointestinal Disorders
Figure 22. Global Oral Contrast Agent Market: Gastrointestinal Disorders (2020-2025) & (K Pcs)
Figure 23. Oral Contrast Agent Consumed in Musculoskeletal Disorders
Figure 24. Global Oral Contrast Agent Market: Musculoskeletal Disorders (2020-2025) & (K Pcs)
Figure 25. Oral Contrast Agent Consumed in Neurological Disorders
Figure 26. Global Oral Contrast Agent Market: Neurological Disorders (2020-2025) & (K Pcs)
Figure 27. Oral Contrast Agent Consumed in Nephrological Disorders
Figure 28. Global Oral Contrast Agent Market: Nephrological Disorders (2020-2025) & (K Pcs)
Figure 29. Global Oral Contrast Agent Sale Market Share by Application (2024)
Figure 30. Global Oral Contrast Agent Revenue Market Share by Application in 2025
Figure 31. Oral Contrast Agent Sales by Company in 2025 (K Pcs)
Figure 32. Global Oral Contrast Agent Sales Market Share by Company in 2025
Figure 33. Oral Contrast Agent Revenue by Company in 2025 ($ millions)
Figure 34. Global Oral Contrast Agent Revenue Market Share by Company in 2025
Figure 35. Global Oral Contrast Agent Sales Market Share by Geographic Region (2020-2025)
Figure 36. Global Oral Contrast Agent Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Oral Contrast Agent Sales 2020-2025 (K Pcs)
Figure 38. Americas Oral Contrast Agent Revenue 2020-2025 ($ millions)
Figure 39. APAC Oral Contrast Agent Sales 2020-2025 (K Pcs)
Figure 40. APAC Oral Contrast Agent Revenue 2020-2025 ($ millions)
Figure 41. Europe Oral Contrast Agent Sales 2020-2025 (K Pcs)
Figure 42. Europe Oral Contrast Agent Revenue 2020-2025 ($ millions)
Figure 43. Middle East & Africa Oral Contrast Agent Sales 2020-2025 (K Pcs)
Figure 44. Middle East & Africa Oral Contrast Agent Revenue 2020-2025 ($ millions)
Figure 45. Americas Oral Contrast Agent Sales Market Share by Country in 2025
Figure 46. Americas Oral Contrast Agent Revenue Market Share by Country (2020-2025)
Figure 47. Americas Oral Contrast Agent Sales Market Share by Type (2020-2025)
Figure 48. Americas Oral Contrast Agent Sales Market Share by Application (2020-2025)
Figure 49. United States Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 50. Canada Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 51. Mexico Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 52. Brazil Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 53. APAC Oral Contrast Agent Sales Market Share by Region in 2025
Figure 54. APAC Oral Contrast Agent Revenue Market Share by Region (2020-2025)
Figure 55. APAC Oral Contrast Agent Sales Market Share by Type (2020-2025)
Figure 56. APAC Oral Contrast Agent Sales Market Share by Application (2020-2025)
Figure 57. China Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 58. Japan Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 59. South Korea Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 60. Southeast Asia Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 61. India Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 62. Australia Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 63. China Taiwan Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 64. Europe Oral Contrast Agent Sales Market Share by Country in 2025
Figure 65. Europe Oral Contrast Agent Revenue Market Share by Country (2020-2025)
Figure 66. Europe Oral Contrast Agent Sales Market Share by Type (2020-2025)
Figure 67. Europe Oral Contrast Agent Sales Market Share by Application (2020-2025)
Figure 68. Germany Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 69. France Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 70. UK Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 71. Italy Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 72. Russia Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 73. Middle East & Africa Oral Contrast Agent Sales Market Share by Country (2020-2025)
Figure 74. Middle East & Africa Oral Contrast Agent Sales Market Share by Type (2020-2025)
Figure 75. Middle East & Africa Oral Contrast Agent Sales Market Share by Application (2020-2025)
Figure 76. Egypt Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 77. South Africa Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 78. Israel Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 79. Turkey Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 80. GCC Countries Oral Contrast Agent Revenue Growth 2020-2025 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Oral Contrast Agent in 2025
Figure 82. Manufacturing Process Analysis of Oral Contrast Agent
Figure 83. Industry Chain Structure of Oral Contrast Agent
Figure 84. Channels of Distribution
Figure 85. Global Oral Contrast Agent Sales Market Forecast by Region (2026-2031)
Figure 86. Global Oral Contrast Agent Revenue Market Share Forecast by Region (2026-2031)
Figure 87. Global Oral Contrast Agent Sales Market Share Forecast by Type (2026-2031)
Figure 88. Global Oral Contrast Agent Revenue Market Share Forecast by Type (2026-2031)
Figure 89. Global Oral Contrast Agent Sales Market Share Forecast by Application (2026-2031)
Figure 90. Global Oral Contrast Agent Revenue Market Share Forecast by Application (2026-2031)